Clinical trial
Expression of VEGF-C and VEGF-CR in Oral Cancers and Premalignant Lesions
NCT00173316 · National Taiwan University Hospital, Other · Unknown status
Key facts
| NCT number | NCT00173316 |
|---|---|
| Title | Expression of VEGF-C and VEGF-CR in Oral Cancers and Premalignant Lesions |
| Official title | The Role of Vascular Endothelial Growth Factor-C (VEGF-C) and Its Receptors Induced Lymphangiogenesis on the Carcinogenesis of Oral Cancers and Premalignant Lesions |
| Lead sponsor | National Taiwan University Hospital, Other |
| Status | Unknown status |
| Study type | Observational |
| Conditions | Oral Cancer |
| Enrollment | 80 |
| Start date | Aug 1, 2004 |
| Completion | Jun 1, 2005 |
| First posted | Sep 15, 2005 |
| Last update posted | Sep 15, 2005 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: